0001055726-19-000004.txt : 20190104
0001055726-19-000004.hdr.sgml : 20190104
20190104163319
ACCESSION NUMBER: 0001055726-19-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190103
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zoth Lota S.
CENTRAL INDEX KEY: 0001278219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 19510531
MAIL ADDRESS:
STREET 1: 334 CR 692
CITY: BUFFALO GAP
STATE: TX
ZIP: 79508
FORMER NAME:
FORMER CONFORMED NAME: ZOTH LOTA S
DATE OF NAME CHANGE: 20040130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330024450
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wf-form4_154663758186763.xml
FORM 4
X0306
4
2019-01-03
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001278219
Zoth Lota S.
660 W. GERMANTOWN PIKE
SUITE 110
PLYMOUTH MEETING
PA
19462
1
0
0
0
Common Stock Option
4.28
2019-01-03
4
A
0
20000
0
A
2029-01-03
Common Stock
20000.0
20000
D
Restricted Stock Unit
2019-01-03
4
A
0
12270
0
A
Common Stock
12270.0
12270
D
This grant was made pursuant to the issuer's non-employee director compensation policy.
The vesting schedule for the 20,000 options is as follows: 5,000 shares vested on January 3, 2019; 5,000 shares will vest on January 3, 2020; 5,000 shares will vest on January 3, 2021; 5,000 shares will vest on January 3, 2022.
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,270 restricted stock units is as follows: 4,090 shares will vest on January 3, 2020; 4,090 shares will vest on January 3, 2021; 4,090 shares will vest on January 3, 2022. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
/s/ Lota Zoth
2019-01-04